The first patient for the proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test by Hera Biotech has been enrolled at UTHealth Houston. Hera Biotech was formed to apply advances in biotechnology to address unmet needs in women’s healthcare. Its lead product is MetriDx™, a novel, non-surgical test that utilizes single-cell microfluidic analysis of proprietary biomarkers for the definitive, early diagnosis and staging of endometriosis.

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kitakyushu General Hospital (“Kitakyushu”), a hospital in the Kyushu area of Japan, entered into an agreement to lease and utilize a second Senhance® Surgical System, at the end of December 2022. Kitakyushu is the first hospital to install multiple Senhance Surgical Systems.

Alteogen Inc. announced today that the company has entered into an exclusive license agreement with Sandoz AG. Under the terms of the agreement, Sandoz will acquire the world-wide rights to use ALT-B4, Alteogen’s novel hyaluronidase derived utilizing Hybrozyme Technology, to develop and commercialize a subcutaneous version of a Sandoz biosimilar product. In addition, the agreement includes an option for Sandoz to license the Hybrozyme technology for two further products.Alteogen will re

Today, Health Net and Community Health System announced they will continue their long-standing partnership to serve residents of Fresno county. Community's complete continuum of services will continue to be available to existing and future Health Net members enrolled in commercial, Medicare and Medi-Cal plans. Community Health System is the largest health system in the Central Valley and includes Community Medical Centers (its hospitals and clinics), as well as a health plan and

Laudio, the leadership operations solution for healthcare, announces the release of new patient rounding and auditing capabilities to address patient experience plus quality and safety needs for its leading health system clients. The platform will streamline and standardize best practices for frontline leaders, making crucial data available in real-time and accessible from a single source of truth.“We launched Laudio a few years ago focused heavily on workflow and automation needed to s

ApolloMD announces a partnership with Cascade365 to work in concert with RIP Medical Debt, resulting in the successful abolishment of more than $350M of patient medical debt spanning over 800,000 patient accounts. Recipients of debt abolishment began receiving notification by way of a RIP branded letter beginning in the month of June. A multispecialty clinical services provider for hospitals and health systems, ApolloMD sees this action as part of a focus on quality patient care. &q

Augusta University Health System has signed a letter of intent with Wellstar Health System to form an innovative new partnership that would expand Augusta University's educational and research missions and allow Wellstar Health System to create a broader affiliation with the university's Medical College of Georgia as AUHS joins the Wellstar Health System. The potential partnership is the culmination of a thoughtful and deliberate process begun in 2019 by AUHS, its governing

In the field of Cardiac science, a relatively new but safe and successful non-surgical technique is advocated, giving new hope for life to patients with specific heart-valve-related conditions. Patients who have Aortic Stenosis, meaning narrowed aortic valves can be benefitted from this procedure. The aortic valve is one of the four valves in the heart and lies in the left ventricle, which is responsible for transferring oxygenated blood to the body. Aortic Stenosis occurs when there is calci

Lightnix Inc. has decided to participate as a partner company in "Innovation Infusion Japan”, an initiative sponsored by AstraZeneca K.K. i2.JP is a new initiative that promotes open innovations in the healthcare field. Its goal is to contribute to next-generation healthcare through partnerships with companies, academia, and government. Lightnix seeks to create innovations in healthcare through the development of intradermal vaccine injection devices and other new drug de

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare  and Searchlight Pharma Inc., a private Canadian-based specialty healthcare company  are pleased to announce that they have entered into a definitive agreement pursuant to which the Purchaser has agreed to acquire all of the issued and outstanding common shares of the Company in exchange for cash consideration of $1.35 per Company Share, representing a 79.8% premium to the 90-day volume-weighted average trading price of the Company S